業績

Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: a randomized controlled trial of repaglinide vs. sulfonylurea

Omori K, Nomoto H, Nakamura A, Takase T, Cho KY, Ono K, Manda N, Kurihara Y,Aoki S, Atsumi T,Miyoshi H

The data of change in macrophage gene expression which induced by perilipin 1 overexpression.

Yamamoto K, Miyoshi H, Cho KY, Nakamura A, Greenberg AS, Atsumi T.

Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages.

The Effect of Everolimus on Refractory Hypoglycemia in a Patient with Inoperable Metastatic Insulinoma Evaluated by Continuous Glucose Monitoring.

Nakamura H, Shimamura S, Yasuda S, Kono M, Kono M,Fujieda Y, Kato M, Oku K, Bohgaki T, Shimizu T, Iwasaki N, Atsumi T.

Ectopic RASGRP2 (CalDAG-GEFI) expression in rheumatoid synovium contributes to the development of destructive arthritis.

Klein K, Kato M, Frank-Bertoncelj M, Kolling C, Ciurea A, Gay S,
Ospelt C. Evaluating the bromodomain protein BRD1 as a therapeutic
target in rheumatoid arthritis. Scientific Reports. in press.

Maeda K, Otomo K, Yoshida N, Abu-Asab MS, Ichinose K, Nishino T, Kono
M, Ferretti A, Bhargava R, Maruyama S, Bickerton S, Fahmy TM, Tsokos
MG, Tsokos GC.
CaMK4 compromises podocyte function in autoimmune and nonautoimmune
kidney disease.
J Clin Invest. 2018 Jul 9. pii: 99507.
PMID: 29985166

Thrombopoietin mimetics for systemic lupus erythematosus with antiphospholipid antibodies should be discussed separately.

Systemic Lupus Erythematosus: nothing stale her infinite variety.

The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody Positive Patients: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository.